Status:
UNKNOWN
European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMO
Lead Sponsor:
Maastricht University Medical Center
Collaborating Sponsors:
European chapter of the Extracorporeal Life Support Organization
Erasmus Medical Center
Conditions:
COVID
SARS-CoV-2
Eligibility:
All Genders
Brief Summary
In the last 10 years, severe acute respiratory infection (SARI) was responsible of multiple outbreaks putting a strain on the public health worldwide. Indeed, SARI had a relevant role in the developme...
Eligibility Criteria
Inclusion
- Laboratory-confirmed COVID-19 infection by real-time PCR (polymerase chain reaction)
- ECMO for treatment severe lung disease COVID-19 related
Exclusion
- Patients treated with ECMO for other concomitant causes.
Key Trial Info
Start Date :
April 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2022
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04366921
Start Date
April 10 2020
End Date
April 1 2022
Last Update
September 5 2021
Active Locations (97)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätskliniken Innsbruck
Innsbruck, Austria
2
Landesklinikum Sankt Polten
Sankt Pölten, Austria
3
Medical University of Vienna
Vienna, Austria
4
Onze Lieve Vrouwziekenhuis Aalst
Aalst, Belgium